Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK ...
Saliva is an easily accessible source of high molecular weight DNA for Oxford Nanopore long-read sequencing applications.
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now ...
11d
Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe
Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic ("IVD") device in the UK and Europe: the GridION (TM) Dx.
Government-backed population genomics projects escalate demand, while AI and long-read sequencing tech enhance data analysis speed and accuracy Whole Genome Sequencing Market Whole Genome Sequencing ...
Oxford Nanopore Technologies is looking forward to “the year of the proteome,” as co-founder and CEO Gordon Sanghera, PhD, labeled 2025 during his presentation at the recent 43rd Annual J.P. Morgan ...
Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...
Oxford Nanopore Technologies (LON:ONT) outlined progress in expanding its nanopore-based sequencing platform and highlighted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback